Improving crop yields and enhancing farm information remain key growth opportunities for Monsanto. Image source: Monsanto.
In rejecting Bayer‘s (NASDAQOTH: BAYRY) $62 billion merger offer, Monsanto (NYSE: MON) said it didn’t think its German rival was crazy for trying to buy the agrichemical giant, but that Bayer would have to be out of its mind if it thought it could buy the business so cheaply.